These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. PATTERNS OF HALLUCINOGENIC DRUG ABUSE. LUDWIG AM, LEVINE J. JAMA; 1965 Jan 11; 191():92-6. PubMed ID: 14233246 [No Abstract] [Full Text] [Related]
4. [LSD and related hallucinogens. History--effect--use and dangers]. Hole G. Munch Med Wochenschr; 1967 Jun 30; 109(26):1389-97. PubMed ID: 4874820 [No Abstract] [Full Text] [Related]
8. Psychedelic drugs, stress, and the ego. The differential diagnosis of psychosis associated with psychotomimetic drug use. Glass GS. J Nerv Ment Dis; 1973 Apr 26; 156(4):232-41. PubMed ID: 4708883 [No Abstract] [Full Text] [Related]
9. Deceptions in the illicit drug market. Cheek FE, Newell S, Joffe M. Science; 1970 Feb 27; 167(3922):1276. PubMed ID: 5460848 [No Abstract] [Full Text] [Related]
10. Psychedelic drugs: the ups and downs of ecstasy. Check E. Nature; 2004 May 13; 429(6988):126-8. PubMed ID: 15141183 [No Abstract] [Full Text] [Related]
11. Psychedelic drugs should be legally reclassified so that researchers can investigate their therapeutic potential. Rucker JJ. BMJ; 2015 May 26; 350():h2902. PubMed ID: 26014506 [No Abstract] [Full Text] [Related]
12. THE USE OF HALLUCINOGENIC, PSYCHOTOMIMETIC, PSYCHEDELIC DRUGS IN NORTH CAROLINA. KEELER MH. N C Med J; 1963 Dec 26; 24():555-7. PubMed ID: 14089896 [No Abstract] [Full Text] [Related]
13. Psychedelic drugs and mystical experience. Pahnke WN. Int Psychiatry Clin; 1969 Dec 26; 5(4):149-62. PubMed ID: 4892137 [No Abstract] [Full Text] [Related]